Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Alzheimer's Drug Discovery Foundation Awards $5.5M in Grants for Diagnostic Development

Alzheimer's Drug Discovery Foundation Awards $5.5M in Grants for Diagnostic Development

Dec 04, 2019
|
staff reporter

NEW YORK — The Alzheimer's Drug Discovery Foundation (ADDF) said on Wednesday that it has awarded $5.5 million in new funding to support the development of blood-based tests for Alzheimer's disease and related dementias.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

In a Different Lab

NPR reports that graduate students in the US are helping with SARS-CoV-2 testing.

Relief Bill Signed

Politico reports President Donald Trump has signed the $2 trillion coronavirus relief package.

Little Bit Improved

A new analysis finds that peer review improves the quality of preprints just a little bit, according to ScienceInsider.

PLOS Studies on Anti-Viral Epigenetic Drugs, Liver Cancer Oncogene, Brazilian HIV Diversity

In PLOS this week: epigenetic drug triggers anti-viral activity, viral diversity among individuals with HIV experiencing virological failure, and more.

May
06
Featured Webinar

The Role of Single-Cell Functional Biomarkers in Next-Generation Cancer Therapies

Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.

What's Popular?

In Molecular Diagnostics

  1. Abbott POC Coronavirus Test Snares FDA Emergency Use Authorization

  2. Bio-Rad Laboratories ddPCR Shows Accuracy Benefits in COVID-19 Detection Studies

  3. Myriad Genetics Seeks Japan Approval for Advanced Pancreatic, Prostate Cancer Companion Diagnostic

  4. Luminex Receives FDA Emergency Use Authorization for Coronavirus Multiplex Panel

  5. FDA Fleshes Out Emergency Guidance for Coronavirus Test Developers

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.